BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7546896)

  • 1. [A critical reading and interpretation of the results of phase III trials and meta-analysis].
    Piedbois P; Buyse M
    Bull Cancer Radiother; 1995; 82(2):73-8. PubMed ID: 7546896
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistics in oncology.
    Land SR; Abrams J; Buyse M; Chappell RJ
    J Clin Oncol; 2008 Aug; 26(22):3668. PubMed ID: 18669450
    [No Abstract]   [Full Text] [Related]  

  • 3. Graphical methods for detecting bias in meta-analysis.
    Ferrer RL
    Fam Med; 1998 Sep; 30(8):579-83. PubMed ID: 9773289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.
    Pildal J; Hróbjartsson A; Jørgensen KJ; Hilden J; Altman DG; Gøtzsche PC
    Int J Epidemiol; 2007 Aug; 36(4):847-57. PubMed ID: 17517809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratios.
    Koller MT; Stijnen T; Steyerberg EW; Lubsen J
    J Clin Epidemiol; 2008 Apr; 61(4):365-72. PubMed ID: 18313561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deriving treatment recommendations from evidence within randomized trials. The role and limitation of meta-analysis.
    Freemantle N; Mason J; Eccles M
    Int J Technol Assess Health Care; 1999; 15(2):304-15. PubMed ID: 10507190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meta-analyses of randomized trials in oncology: pros and cons].
    Hill C; Pignon JP
    Bull Cancer; 1999 Mar; 86(3):259-64. PubMed ID: 10210759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials.
    Keus F; Wetterslev J; Gluud C; Gooszen HG; van Laarhoven CJ
    Am J Gastroenterol; 2009 Mar; 104(3):546-51. PubMed ID: 19262513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bias in meta-analysis and funnel plot asymmetry.
    Biljana M; Jelena M; Branislav J; Milorad R
    Stud Health Technol Inform; 1999; 68():323-8. PubMed ID: 10724898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis in medical research: potentials and limitations.
    Zwahlen M; Renehan A; Egger M
    Urol Oncol; 2008; 26(3):320-9. PubMed ID: 18452828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of risk of bias in randomized clinical trials in surgery.
    Gurusamy KS; Gluud C; Nikolova D; Davidson BR
    Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drawing generalized causal inferences based on meta-analysis.
    Matt GE
    NIDA Res Monogr; 1997; 170():165-82. PubMed ID: 9154257
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigating patient exclusion bias in meta-analysis.
    Tierney JF; Stewart LA
    Int J Epidemiol; 2005 Feb; 34(1):79-87. PubMed ID: 15561753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of a wide perspective on meta-analysis. It may be of crucial significance for the patients].
    Gøtzsche PC
    Ugeskr Laeger; 2000 Oct; 162(42):5601. PubMed ID: 11059294
    [No Abstract]   [Full Text] [Related]  

  • 15. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells.
    Rücker G; Schwarzer G; Carpenter J; Olkin I
    Stat Med; 2009 Feb; 28(5):721-38. PubMed ID: 19072749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of meta-analysis in monitoring clinical trials.
    Begg CB
    Stat Med; 1996 Jun; 15(12):1299-306; discussion 1307-11. PubMed ID: 8817803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence based medicine. The facts in the North countries].
    Lemarié E
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S9-10S12. PubMed ID: 17127953
    [No Abstract]   [Full Text] [Related]  

  • 18. Meta-analysis and meta-analytic monitoring of clinical trials.
    Feinstein AR
    Stat Med; 1996 Jun; 15(12):1273-80; discussion 1281-3. PubMed ID: 8817801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further statistics in dentistry Part 8: Systematic reviews and meta-analyses.
    Petrie A; Bulman JS; Osborn JF
    Br Dent J; 2003 Jan; 194(2):73-8. PubMed ID: 12577072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous toxicity monitoring in phase II trials in oncology.
    Ivanova A; Qaqish BF; Schell MJ
    Biometrics; 2005 Jun; 61(2):540-5. PubMed ID: 16011702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.